On January 3, 2024, CareTalk published an opinion piece authored by Michael C. Barnes, Counsel to Aimed Alliance. The article explains that the CBD consumer product market is largely unregulated, and consumers have no way to be sure that the product they buy contains the ingredients listed on the label — and that it does not contain intoxicants or contaminants. Congress should enact legislation to ensure that consumers have access to safe, regulated CBD products. Congress must also make certain that the FDA has adequate resources and capacity to establish and enforce compliance with new CBD consumer product regulations. Read the full article here.
Last Updated on January 23, 2024 by Aimed Alliance
